Bionano Genomics, Inc.【BNGO】
時価総額
$373.4万
PER
ゲノム解析ソリューションの新興企業。光学ゲノムマッピング（OGM）機器、VIA解析ソフト、Ionic精製システムを展開。分析ソフト買収で約5,230万ドルの現金支払い、DNA抽出企業買収で約3,200万ドルの現金支払い。米国中心に展開。
| 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | 2023年 12月31日 | 2024年 12月31日 | |
| Product revenue | - | 9 | 6 | 12 | 20 | 27 | 27 |
| Service and other revenue | - | 655,064 | 2 | 6 | 7 | 9 | 4 |
| Total revenue | - | 10 | 9 | 18 | 28 | 36 | 31 |
| Product revenue | 9 | 6 | 5 | 11 | 16 | 20 | 28 |
| Service and other revenue | 149,284 | 272,454 | 919,729 | 4 | 6 | 6 | 2 |
| Total cost of revenue | 9 | 7 | 6 | 14 | 22 | 27 | 30 |
| Research and development | 9 | 9 | 10 | 22 | 49 | 54 | 25 |
| Selling, general and administrative | 14 | 20 | 31 | 58 | 89 | 93 | 52 |
| Goodwill impairment | - | - | - | - | - | 77 | - |
| Asset Impairment Charges | - | - | - | - | - | - | 20 |
| Restructuring costs | - | - | - | - | - | - | 8 |
| Total operating expenses | 24 | 29 | 41 | 81 | 138 | 225 | 104 |
| Loss from operations | -20,415,085 | -25,874,906 | -38,551,322 | -77 | -132 | -215 | -104 |
| Interest income | - | - | - | 0 | 2 | 3 | 2 |
| Other expense | - | - | - | -0 | -0 | 3 | -10 |
| Total other expense | 2 | -3,919,116 | -2,525,836 | -1 | 1 | -17 | -8 |
| Loss before income taxes | -18,480,881 | -29,794,022 | -41,077,158 | -78 | -131 | -232 | -112 |
| Provision for income taxes | 15,511 | 21,048 | 29,193 | -6 | 2 | 0 | 0 |
| Net loss | -18,496,392 | -29,815,070 | -41,106,351 | -72 | -133 | -232 | -112 |
| Earnings Per Share, Basic | - | - | - | - | -0.46 | -6.81 | -88.13 |
| Earnings Per Share, Diluted | - | - | - | - | -0.46 | -6.81 | -88.13 |